- Filed
- Jun 25, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jun 15, 2024 | 68.69M sh |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $114.93M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $119.27M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $92.41M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $91.68M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $92.41M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $91.68M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $160.68M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $164.5M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $203.48M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $207.88M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 68.69M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $2.4K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $2.66M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $811.86K |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$1.89M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$709.13K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $553.21K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $5.18M |
| Revenue | Q1 2024 · Mar 31, 2023 | $5.73M |